(In the process of vascularization, CCL2 binding to CCR2 on tumor cells triggers ILK and MEK1/2 pathways, inhibits miR-29c to promote the generation of VEGF-A, and further promotes the formation of neovascularization. The gene discussed is CCL2; the disease is neoplasm.